Companies 0 See All
Hedge Funds 0 See All
Insiders 0 See All
Institutional Investors 0 See All
Click here to see all results for
Home > Insider Trading > Novo Nordisk A S

Novo Nordisk A S (NVO)

Market is closed
News
Artisan Global Opportunities Fund Trimmed its Position in Novo Nordisk A/S (NVO)

Artisan Global Opportunities Fund Trimmed its Position in Novo Nordisk A/S (NVO)

Artisan Partners, an investment management company, released its “Artisan Global Opportunities Fund” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.

Keep Reading →

April 3rd, 2025 - Hedge Fund Investor Letters News

12 Best ADR Stocks to Buy According to Hedge Funds

12 Best ADR Stocks to Buy According to Hedge Funds

American Depositary Receipts (ADR) are US-listed securities that represent shares in foreign companies, allowing American investors to gain exposure to international equities without dealing with foreign...

Keep Reading →

March 27th, 2025 - Hedge Funds News

10 Best Beaten Down Stocks to Buy According to Analysts

10 Best Beaten Down Stocks to Buy According to Analysts

JPMorgan released a market update where it highlighted the US Fed’s recent decision to keep the rates unchanged.

Keep Reading →

March 25th, 2025 - Hedge Funds News

11 Best Extremely Profitable Stocks to Buy According to Analysts

11 Best Extremely Profitable Stocks to Buy According to Analysts

While the S&P 500 is hovering near correction territory, marking five years since its COVID-19 drawdown. Wyne noted that the risks appear evenly distributed between bullish and bearish outlooks.

Keep Reading →

March 24th, 2025 - Hedge Funds News

10 Stocks Wall Street Is Calling Bullish Amid Market Turmoil

10 Stocks Wall Street Is Calling Bullish Amid Market Turmoil

The S&P 500 is down 8.6% in a month while the Nasdaq has lost nearly 13%.

Keep Reading →

March 19th, 2025 - News Stock Analysis

Novo Nordisk A/S (NVO) Traded Lower Due To Investor Disappointment Over Its New Drug In Obesity

Novo Nordisk A/S (NVO) Traded Lower Due To Investor Disappointment Over Its New Drug In Obesity

Burke Wealth Management, an investment management company, released its “Focused Growth Strategy” fourth quarter 2024 investor letter. A copy of the letter can be downloaded here.

Keep Reading →

March 19th, 2025 - Hedge Fund Investor Letters News

Novo Nordisk A/S (NVO) Dropped as Trial Results Fell Short of Expectations

Novo Nordisk A/S (NVO) Dropped as Trial Results Fell Short of Expectations

Polen Capital, an investment management company, released its “Polen Global Growth Strategy” fourth-quarter 2024 investor letter. A copy of the letter can be downloaded here.

Keep Reading →

March 19th, 2025 - Hedge Fund Investor Letters News

10 Stocks Market Experts are Talking About These Days

10 Stocks Market Experts are Talking About These Days

Piper Sandler’s Chief Market Technician Craig Johnson said in a latest program on CNBC that despite the recent market volatility and “negative” headlines, he sees buying opportunities for long-term...

Keep Reading →

March 16th, 2025 - Hedge Funds News

10 Best Diabetes Stocks To Buy According to Billionaires

10 Best Diabetes Stocks To Buy According to Billionaires

The WHO estimates that 422 million people worldwide suffer from diabetes, with the majority residing in low- or middle-income countries.

Keep Reading →

March 14th, 2025 - Hedge Funds News

Why Novo Nordisk (NVO) Is Rising Today

Why Novo Nordisk (NVO) Is Rising Today

Novo Nordisk (NVO) is advancing 4% after the drug maker cut the price of its very popular weight-loss drug, Wegovy, by over 50%.

Keep Reading →

March 5th, 2025 - Market Movers News

Insider Monkey Quarterly Strategy
+373.4% Insider Monkey Quarterly Strategy
+154.9% Benchmark50% S&P 500 ETF and 50% Russell 2000 ETF
300%
200%
100%
Subscribe Now

Returns since its inception in May 2014 (through February 19th, 2025)